×
About 1,385 results

ALLMedicine™ Insulin Pumps Center

Research & Reviews  605 results

Insulin dose optimization using an automated artificial intelligence-based decision sup...
https://doi.org/10.1038/s41591-020-1045-7
Nature Medicine; Nimri R, Battelino T et. al.

Sep 10th, 2020 - Despite the increasing adoption of insulin pumps and continuous glucose monitoring devices, most people with type 1 diabetes do not achieve their glycemic goals1. This could be related to a lack of expertise or inadequate time for clinicians to an...

A clinical review of the t:slim X2 insulin pump.
https://doi.org/10.1080/17425247.2020.1814734
Expert Opinion on Drug Delivery; Berget C, Lange S et. al.

Aug 27th, 2020 - Insulin pumps are commonly used for intensive insulin therapy to treat type 1 diabetes in adults and youth. Insulin pump technologies have advanced dramatically in the last several years to integrate with continuous glucose monitors (CGM) and inco...

Technology Integration: The Role of the Diabetes Care and Education Specialist in Pract...
https://doi.org/10.1177/0145721720935123
The Diabetes Educator; Isaacs D, Cox C et. al.

Aug 11th, 2020 - Technology is rapidly evolving and has become an integral component of diabetes care. People with diabetes and clinicians are harnessing a variety of technologies, including connected blood glucose meters, continuous glucose monitors, insulin pump...

Isobornyl acrylate and diabetic devices steal the Show for the 2020 American Contact De...
https://www.ncbi.nlm.nih.gov/pubmed/32716991
Cutis Nath N, Reeder M et. al.

Jul 27th, 2020 - Diabetic devices including glucose monitoring systems and insulin pumps are used worldwide and are increasingly recognized as a source of irritant contact dermatitis and allergic contact dermatitis (ACD). Isobornyl acrylate is a chemical used in t...

An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344799
International Journal of Environmental Research and Public Health; Morgovan C, Cosma SA et. al.

Jun 24th, 2020 - The prevalence of diabetes mellitus (DM) rises constantly each year worldwide. Because of that, the funds allocated for the DM treatment have increased over time. Regarding the number of DM cases, Romania is among the top ten countries in Europe. ...

see more →

Guidelines  7 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Association; Choudhary P, Campbell F et. al.

Feb 18th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

Diabetes Technology: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S71

Dec 17th, 2018 - Diabetes technology is the term used to describe the hardware, devices, and software that people with diabetes use to help manage blood glucose levels, stave off diabetes complications, reduce the burden of living with diabetes, and improve qualit...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; Grunberger G, Handelsman Y et. al.

Mar 16th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

JDRF Statement: Animas Exits the Insulin Pump Business - Guideline
http://www.jdrf.org/blog/2017/10/05/jdrf-statement-animas-exits-the-insulin-pump-business/
Juvenile Diabetes Research Foundation International

Oct 4th, 2017 - The choice of a pump should be made by people with diabetes and their doctors, and JDRF does not endorse products. For those Animas customers needing a new pump, the following links might be helpful.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  663 results

Insulin dose optimization using an automated artificial intelligence-based decision sup...
https://doi.org/10.1038/s41591-020-1045-7
Nature Medicine; Nimri R, Battelino T et. al.

Sep 10th, 2020 - Despite the increasing adoption of insulin pumps and continuous glucose monitoring devices, most people with type 1 diabetes do not achieve their glycemic goals1. This could be related to a lack of expertise or inadequate time for clinicians to an...

A clinical review of the t:slim X2 insulin pump.
https://doi.org/10.1080/17425247.2020.1814734
Expert Opinion on Drug Delivery; Berget C, Lange S et. al.

Aug 27th, 2020 - Insulin pumps are commonly used for intensive insulin therapy to treat type 1 diabetes in adults and youth. Insulin pump technologies have advanced dramatically in the last several years to integrate with continuous glucose monitors (CGM) and inco...

Technology Integration: The Role of the Diabetes Care and Education Specialist in Pract...
https://doi.org/10.1177/0145721720935123
The Diabetes Educator; Isaacs D, Cox C et. al.

Aug 11th, 2020 - Technology is rapidly evolving and has become an integral component of diabetes care. People with diabetes and clinicians are harnessing a variety of technologies, including connected blood glucose meters, continuous glucose monitors, insulin pump...

Isobornyl acrylate and diabetic devices steal the Show for the 2020 American Contact De...
https://www.ncbi.nlm.nih.gov/pubmed/32716991
Cutis Nath N, Reeder M et. al.

Jul 27th, 2020 - Diabetic devices including glucose monitoring systems and insulin pumps are used worldwide and are increasingly recognized as a source of irritant contact dermatitis and allergic contact dermatitis (ACD). Isobornyl acrylate is a chemical used in t...

An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344799
International Journal of Environmental Research and Public Health; Morgovan C, Cosma SA et. al.

Jun 24th, 2020 - The prevalence of diabetes mellitus (DM) rises constantly each year worldwide. Because of that, the funds allocated for the DM treatment have increased over time. Regarding the number of DM cases, Romania is among the top ten countries in Europe. ...

see more →

News  109 results

Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-minimed-insulin-pumps-incorrect-insulin-dosing

The FDA has identified this as a Class I recall, the most serious type of recall.  Use of these devices may cause serious injuries or death. Recalled Product MiniMed 600 Series Insulin Pumps Model 630G (MMT-1715) - all lots before October 2019 Mod...

FDA issues MiniMed600 insulin pump recall
https://www.mdedge.com/endocrinology/article/217251/diabetes/fda-issues-minimed600-insulin-pump-recall?channel=39313
Christopher Palmer

Feb 12th, 2020 - Medtronic is recalling certain MiniMed600 insulin pumps as part of a class I recall, the most serious kind of recall, because of a potentially fatal risk of incorrect dosing, according to a Food and Drug Administration MedWatch release. Wikimedia.

Medtronic Recalls Remote Controllers for MiniMed Insulin Pumps for Potential Cybersecurity Risks | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-remote-controllers-minimed-insulin-pumps-potential-cybersecurity-risks

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death Other cybersecurity issues related to specified Medtronic MiniMed Insulin Pumps were communicated in the FDA...

Certain Medtronic MiniMed Insulin Pumps Have Potential Cybersecurity Risks: FDA Safety Communication | FDA
https://www.fda.gov/medical-devices/safety-communications/certain-medtronic-minimed-insulin-pumps-have-potential-cybersecurity-risks-fda-safety-communication

Español Date Issued: June 27, 2019 The FDA is warning patients and health care providers that certain Medtronic MiniMed™ insulin pumps have potential cybersecurity risks. Patients with diabetes using these models should switch their insulin pump t...

FDA issues warning on insulin pump cybersecurity weakness
https://www.mdedge.com/internalmedicine/article/203772/diabetes/fda-issues-warning-insulin-pump-cybersecurity-weakness?channel=206
Jennifer Reising

Jun 20th, 2019 - The Food and Drug Administration has issued a warning to patients and health care providers that a pair of Medtronic insulin pumps are being recalled because of potential cybersecurity risks, according to a press release. The affected devices are.

see more →